Up to 40% of patients with bipolar depression are initially misdiagnosed, contributing to inappropriate treatment and delays in providing proper care. Negative symptoms of schizophrenia, such as apathy, loss of pleasure, and social withdrawal, are also underrecognized and undertreated.
Clinicians in psychiatry or primary care need to understand not only the nuances of diagnosis and assessment but also the evolving therapeutic landscape for both of these conditions, including the emergence of treatment options that leverage both the D2 and D3 dopamine receptors.
This curriculum is designed to support a shared focus and collaborative effort for specialists and primary care providers alike in the timely diagnosis and effective management of bipolar depression and schizophrenia, contributing to outcomes that include symptom control, improved daily functioning, and enhanced quality of life.
Do you have a question about depressive symptoms in your patients with bipolar disorder or negative symptoms in your patients with schizophrenia?
Our faculty experts will provide answers periodically to common and perplexing clinical problems. Click here to submit your question.
Collaborating with preeminent academic institutions and medical societies produces balanced, credible CME/CE activities that are relevant and practical in day-to-day clinical practice.
Supported by an educational grant from Allergan